# Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients

> **NCT00849368** · PHASE1 · COMPLETED · sponsor: **University of Zurich** · enrollment: 6 (actual)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Azathioprine / Allopurinol

## Key facts

- **NCT ID:** NCT00849368
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849368, "Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00849368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*